A randomized controlled trial comparing changes in fitness with or without supervised exercise in patients initiated on enzalutamide and androgen deprivation therapy for non-metastatic castration-sensitive prostate cancer (EXTEND)
Michael R. Harrison, Paul G. Davis, Michel G. Khouri, David B. Bartlett, Rajan T. Gupta, Andrew J. Armstrong, Megan McNamara, Tian Zhang, Monika Anand, Kelly Onyenwoke, Sara Edwardson, Danielle Craig, Meghan Michalski, Yuan Wu, Taofik Oyekunle, Brian J. Coyne, Aubrie Coburn, Lee W. Jones, Daniel J. George
Topics & Concepts
MedicineEnzalutamideProstate cancerAndrogen deprivation therapyCardiorespiratory fitnessClinical endpointInternal medicineRandomized controlled trialAdverse effectAerobic exerciseQuality of life (healthcare)VO2 maxAndrogen receptorUrologyOncologyCancerBlood pressureHeart rateNursingProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentBone health and treatments